Comparisons11 min readUpdated 2026-03-22

    How to Switch from Sequence to Trimi and Save 60%

    Step-by-step guide to switching from Sequence to Trimi for GLP-1 treatment. Learn how to navigate contract terms, ensure dosing continuity, and start saving up to 60% on your monthly medication costs immediately.

    Why Sequence Patients Are Switching to Trimi

    The primary driver of the Sequence-to-Trimi switch is straightforward economics. Sequence patients are paying $199 to $399 per month for GLP-1 treatment that is available at Trimi for $99 per month. The medication is pharmacologically identical, the medical oversight is comparable, and the treatment outcomes are driven by the same active ingredient. The premium difference funds Sequence's genetic testing, platform, and brand experience — features that many patients conclude are not worth $100 to $300 per month once the initial novelty subsides.

    Contract inflexibility adds urgency to the switching decision. Patients locked into multi-month Sequence commitments often begin planning their exit as soon as they realize the premium is not delivering proportionally better results. By understanding the switching process in advance, you can time your transition to minimize overlap costs, avoid treatment gaps, and begin saving immediately.

    Step-by-Step Switching Guide

    Step 1: Review your Sequence contract terms

    Check your remaining commitment period, early cancellation fees, and billing cycle dates. Calculate whether the monthly savings from switching exceed any cancellation penalties. If your contract ends within one to two months, it may be simpler to wait.

    Step 2: Request your medical records and genetic data

    Contact Sequence to request a complete copy of your medical records, including genetic test results, dosing history, lab results, and provider notes. You are entitled to these under HIPAA. Allow up to 30 days for processing, though most requests are fulfilled faster.

    Step 3: Begin Trimi onboarding (while still on Sequence)

    Start the Trimi intake process one to two weeks before your remaining Sequence medication runs out. Complete the medical intake form and schedule your provider consultation. This overlap ensures you have continuity.

    Step 4: Complete your Trimi provider consultation

    Your Trimi provider will review your treatment history, confirm your current dose, and create your new treatment plan. Share your Sequence dosing records and any relevant genetic data. The consultation typically occurs within one to two business days.

    Step 5: Receive Trimi medication and cancel Sequence

    Once your Trimi medication arrives and you have confirmed the dose is correct, proceed with canceling your Sequence subscription. Document your cancellation for your records. Begin your Trimi medication at your next scheduled dose.

    What Changes and What Stays the Same

    AspectChanges?Details
    MedicationNoSame compounded semaglutide or tirzepatide
    DoseNoTrimi continues your current dose
    Monthly costYes (lower)Save $100–$300/mo
    Genetic testing accessYes (lost)Save your results before canceling
    Contract obligationYes (none)Trimi is month-to-month
    ProviderYes (new provider)Board-certified Trimi clinician

    Navigating Sequence Contract Cancellation

    Sequence's contract commitments add complexity to the switching process. If you are within your commitment period, review the specific terms of your agreement to understand early termination fees. In some cases, the monthly savings from switching immediately outweigh the one-time cancellation fee, making it financially advantageous to switch even before your contract ends.

    For example, if your Sequence cancellation fee is $200 and you save $200 per month by switching to Trimi, the cancellation fee is recouped in a single month. If you have six or more months of treatment remaining, the total savings far exceed the one-time fee. Run the numbers for your specific situation before deciding whether to wait out your contract or switch immediately. For detailed cancellation instructions, see our Sequence cancellation guide.

    Calculate: will monthly savings exceed the cancellation fee within one to two months?

    Document your cancellation request in writing for your records

    Monitor your bank statements for unexpected charges after cancellation

    Do not cancel Sequence until your Trimi medication has arrived

    Your Savings After Switching

    The financial impact of switching from Sequence to Trimi is immediate and substantial. A patient switching from Sequence's semaglutide program at $299 per month to Trimi at $99 per month saves $200 every month — $2,400 over the next twelve months. For tirzepatide patients at Sequence's premium tiers, the savings can exceed $3,000 annually. These savings begin from the first month on Trimi and continue for the duration of your treatment.

    If you are ready to switch, visit Trimi's pricing page to see current rates and begin the onboarding process. The sooner you start, the sooner you begin saving. With Trimi's month-to-month flexibility, there is zero risk — if for any reason Trimi does not meet your expectations, you can adjust your plan or pause at any time with no penalties.

    Frequently Asked Questions

    Can I switch from Sequence to Trimi mid-contract?

    You can initiate a switch at any time, but be aware that Sequence may impose early cancellation fees if you leave before your contract commitment period ends. Review your Sequence agreement to understand any financial obligations. If you are close to the end of your commitment, it may be worth waiting to avoid penalties. If the monthly savings from switching exceed the cancellation fee, switching immediately may still make financial sense.

    Will my dose continue seamlessly when I switch?

    Yes, Trimi will continue your current medication dose without requiring you to restart titration. Your Trimi provider will review your complete dosing history and current regimen during the intake consultation and create a treatment plan that picks up exactly where Sequence left off. There is no clinical need to reduce your dose or restart the escalation process when changing providers.

    How much will I save by switching from Sequence to Trimi?

    Most Sequence patients save $100 to $300 per month by switching to Trimi. Over a twelve-month period, this translates to $1,200 to $3,600 in total savings. Patients on Sequence's highest-tier plans with tirzepatide at elevated doses see the largest savings because the cost gap between Sequence and Trimi is widest at premium plan levels and higher dose tiers.

    What do I lose by leaving Sequence?

    You will lose access to Sequence's genetic testing data (request a copy before canceling), the Sequence platform and app, and any ongoing relationship with your Sequence provider. You will not lose any medical progress, medication effectiveness, or treatment continuity. The GLP-1 medication you receive from Trimi is pharmacologically identical to what Sequence provided.

    How long does the switch take?

    Trimi's onboarding process typically takes three to seven days from initial intake to medication delivery. If you start the process while you still have a week or more of Sequence medication remaining, you should experience no gap in treatment. The key is timing your Trimi onboarding to overlap with the end of your Sequence supply.

    Should I request my medical records from Sequence?

    Yes, request your complete medical records including genetic test results, dosing history, and provider notes before canceling. You have a legal right to these records under HIPAA. While Trimi does not require genetic data to manage your treatment, having your complete medical history is valuable for your personal records and may be useful for any future healthcare needs.

    Can I switch to Trimi if Sequence prescribed a different medication than I want?

    Yes. Trimi offers both semaglutide and tirzepatide, and your Trimi provider can discuss which medication is most appropriate for your clinical goals. If you want to continue the same medication Sequence prescribed, Trimi can accommodate that. If you want to explore switching medications (for example, from semaglutide to tirzepatide or vice versa), your Trimi provider can evaluate that option as well.

    Sources & References

    1. Sequence. Official terms of service and cancellation policies. 2026.
    2. STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
    3. JAMA trial on continued weekly semaglutide versus placebo for weight-loss maintenance (PubMed).
    4. FDA guidance on compounding and the FDA.
    5. U.S. Department of Health and Human Services. "Your Rights Under HIPAA." HHS, 2024.
    6. American Board of Obesity Medicine. "Best Practices in GLP-1 Therapy Transitions." 2025.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before switching any medication or treatment program. Trimi is a competing provider; this guide is presented fairly but readers should verify current information directly with each provider.

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: May 19, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Clinician-reviewed Trimi guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Clinician-reviewed Trimi guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares to brand alternatives.

    Start your GLP-1 journey — from $99/mo

    Get Started